Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aspira Womans Health Inc (AWH)

Aspira Womans Health Inc (AWH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,846
  • Shares Outstanding, K 12,344
  • Annual Sales, $ 9,150 K
  • Annual Income, $ -16,690 K
  • 60-Month Beta 1.61
  • Price/Sales 4.72
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AWH with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.36
  • Number of Estimates 1
  • High Estimate -0.36
  • Low Estimate -0.36
  • Prior Year -10.94
  • Growth Rate Est. (year over year) +96.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.51 +35.46%
on 04/09/24
3.75 -9.33%
on 03/25/24
-0.25 (-6.85%)
since 03/22/24
3-Month
2.51 +35.46%
on 04/09/24
5.65 -39.82%
on 01/30/24
-0.73 (-17.68%)
since 01/24/24
52-Week
2.31 +47.27%
on 07/27/23
6.75 -49.63%
on 09/01/23
-2.00 (-37.04%)
since 04/24/23

Most Recent Stories

More News
2 Cheap Stocks The Insiders Are Buying 

Aspire Women's Health and Genesco are turning corners and their insiders are buying after several quarters of inactivity.

GCO : 26.10 (-2.50%)
AWH : 3.40 (+0.29%)
New Strong Buy Stocks for May 11th

AMEH, PYCR, AWH, SAND and MCD have been added to the Zacks Rank #1 (Strong Buy) List on May 11, 2023.

MCD : 273.31 (-1.29%)
AWH : 3.40 (+0.29%)
SAND : 5.40 (+0.75%)
AMEH : 40.82 (-2.11%)
PYCR : 17.27 (-1.54%)
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?

Here is how Cardinal Health (CAH) and Aspira (AWH) have performed compared to their sector so far this year.

CAH : 103.21 (-0.15%)
AWH : 3.40 (+0.29%)
What Makes Aspira (AWH) a New Buy Stock

Aspira (AWH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AWH : 3.40 (+0.29%)
Aspira (AWH) Reports Q4 Loss, Misses Revenue Estimates

Aspira (AWH) delivered earnings and revenue surprises of 33.33% and 10.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AWH : 3.40 (+0.29%)
SIEN : 0.1740 (-18.69%)
Has Aspira Women's Health (AWH) Outpaced Other Medical Stocks This Year?

Here is how Aspira (AWH) and Biomea Fusion, Inc. (BMEA) have performed compared to their sector so far this year.

AWH : 3.40 (+0.29%)
BMEA : 11.02 (+0.36%)
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates

Sight Sciences, Inc. (SGHT) delivered earnings and revenue surprises of 16.67% and 0.80%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SGHT : 5.68 (+0.71%)
AWH : 3.40 (+0.29%)
Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of 30.23% and 9.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

STIM : 3.81 (-1.22%)
AWH : 3.40 (+0.29%)
Asensus Surgical (ASXC) Reports Q4 Loss, Lags Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0% and 1.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ASXC : 0.2460 (-1.20%)
AWH : 3.40 (+0.29%)
Is ASLAN Pharmaceuticals (ASLN) Stock Outpacing Its Medical Peers This Year?

Here is how ASLAN Pharmaceuticals Ltd. (ASLN) and Aspira (AWH) have performed compared to their sector so far this year.

ASLN : 0.4700 (+0.21%)
AWH : 3.40 (+0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Aspira Women's Health Inc. engaged in the discovery, development and commercialization of testing options and bio-analytical solutions for women's health. Aspira Women's Health Inc., formerly known as Vermillion Inc., is based in AUSTIN, Texas.

See More

Key Turning Points

3rd Resistance Point 3.61
2nd Resistance Point 3.56
1st Resistance Point 3.48
Last Price 3.40
1st Support Level 3.35
2nd Support Level 3.30
3rd Support Level 3.22

See More

52-Week High 6.75
Fibonacci 61.8% 5.05
Fibonacci 50% 4.53
Fibonacci 38.2% 4.01
Last Price 3.40
52-Week Low 2.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar